Krystal Biotech Inc.
(KRYS) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
158.33
0.10%
After-hours Jan 03, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Revenue | 50.70M | n/a | n/a | n/a | n/a | 1.03M | n/a | n/a |
Cost of Revenue | 3.09M | 4.05M | 2.77M | 1.85M | 974.00K | 141.00K | 23.00K | 2.00K |
Gross Profit | 47.60M | -4.05M | -2.77M | -1.85M | -974.00K | 886.00K | -23.00K | -2.00K |
Operating Income | -109.73M | -145.20M | -68.28M | -33.00M | -22.08M | -11.92M | -4.77M | -1.14M |
Interest Income | 22.62M | 5.22M | 197.00K | 832.00K | 2.99M | n/a | n/a | n/a |
Pretax Income | 12.90M | -139.97M | -69.57M | -32.17M | -19.09M | -10.89M | -7.92M | -1.15M |
Net Income | 10.93M | -139.97M | -69.57M | -32.17M | -19.09M | -10.89M | -7.92M | -1.15M |
Selling & General & Admin | 98.40M | 77.73M | 40.39M | 15.06M | 6.46M | 4.16M | 1.56M | 402.00K |
Research & Development | 46.43M | 42.46M | 27.88M | 17.94M | 15.62M | 7.76M | 3.21M | 741.00K |
Other Expenses | 12.50M | 25.00M | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 157.33M | 120.20M | 68.28M | 33.00M | 22.08M | 11.92M | 4.77M | 1.14M |
Interest Expense | n/a | 5.22M | 1.49M | n/a | n/a | 1.03M | 3.15M | 7.00K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 147.93M | 120.20M | 68.28M | 33.00M | 22.08M | 11.92M | 4.77M | 1.14M |
Income Tax | 1.97M | 34.05M | 2.73M | 1.64M | 576.14K | -20.14K | n/a | n/a |
Shares Outstanding (Basic) | 27.15M | 25.49M | 22.20M | 18.79M | 15.90M | 11.20M | 5.36M | 4.28M |
Shares Outstanding (Diluted) | 27.75M | 25.49M | 22.20M | 18.79M | 15.90M | 11.20M | 5.36M | 4.28M |
EPS (Basic) | 0.40 | -5.49 | -3.13 | -1.71 | -1.2 | -0.97 | -1.48 | -0.27 |
EPS (Diluted) | 0.39 | -5.49 | -3.13 | -1.71 | -1.2 | -0.97 | -1.48 | -0.27 |
EBITDA | 17.90M | -145.20M | -65.31M | -30.32M | -18.11M | -10.75M | -4.63M | -1.14M |
Depreciation & Amortization | 5.01M | 4.05M | 2.77M | 1.85M | 974.00K | 141.00K | 23.00K | 2.00K |